The Safety of EXCOR® Pediatric Was Evaluated by Summarizing the Serious Adverse Event Rate Experienced While the Subject Was Supported on the Device. [clinicaltrials_resource:NCT00583661/outcome/1]
outcome [clinicaltrials_vocabulary:outcome]
The Safety of EXCOR® Pediatric Was Evaluated by Summarizing the Serious Adverse Event Rate Experienced While the Subject Was Supported on the Device. [clinicaltrials_resource:NCT00583661/outcome/1]
Bio2RDF identifier
NCT00583661/outcome/1
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:NCT00583661/outcome/1
analysis [clinicaltrials_vocabulary:analysis]
group [clinicaltrials_vocabulary:group]
measure [clinicaltrials_vocabulary:measure]
population [clinicaltrials_vocabulary:population]
All 48 participants were inclu ...... ed around the point estimates.
All subjects implanted with the device were included in this analysis.
safety issue [clinicaltrials_vocabulary:safety-issue]
time frame [clinicaltrials_vocabulary:time-frame]
Participants were followed while on device support, an average of 58 days
type [clinicaltrials_vocabulary:type]
alternate
The Safety of EXCOR® Pediatric ...... t Was Supported on the Device.
@en
identifier
clinicaltrials_resource:NCT00583661/outcome/1
title
The serious adverse event rate ...... for each primary study cohort.
@en
type
label
The Safety of EXCOR® Pediatric ...... esource:NCT00583661/outcome/1]
@en